Delivery Order SPE2DB22D1106-SPE2DB24FDVF5
Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourceberen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Trokendi XR 25 mg capsule, a prescription medication, at a firm fixed price of $1,216.17. The period of performance runs through December 26, 2023. The contract does not have a set-aside designation. As a prime contractor, AmerisourceBergen Drug Corp has...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Trokendi XR 100 mg capsules (30-count) with a ceiling value of $3,369.96. This firm fixed-price delivery order, which must be completed by January 23, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The award was not set aside for any specific...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,383.94 firm fixed price contract is for the supply of 4,565,564,019 units of the pharmaceutical product Trokendi XR 50 mg capsules. The contract has a period of performance through August 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various military treatment...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,076.16 contract is for the delivery of Trokendi XR 25 mg capsules to support military treatment programs and medical facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $6,003.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,769.16 firm fixed-price delivery order is for the supply of Trokendi XR 25 mg capsules, a medication used for neurological treatments. The contract has an ultimate completion date of July 17, 2025 and was not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,148.36 firm fixed-price contract is for the delivery of Trokendi XR 200 mg capsules. The award is not designated as a set-aside contract. The contract is issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,698.07 to AmerisourceBergen Drug Corp for Trokendi XR 25 mg capsules (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999 and extends through December 2026. The product will...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDVF5Delivery Order
This is a $1,168.15 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Trokendi XR 50 mg capsules, a pharmaceutical product, to support DLA Troop Support Medical programs and facilities. AmerisourceBergen Drug Corp, as a prime contractor, has a history of providing pharmaceuticals, medical supplies, and related distribution services to the DLA. The contract has a completion date of January 17, 2024 and does not have a set-aside designation.
Generated 4/16/24, 5:58 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/16/24 |